Literature DB >> 25139019

Dietary pectin-derived acidic oligosaccharides improve the pulmonary bacterial clearance of Pseudomonas aeruginosa lung infection in mice by modulating intestinal microbiota and immunity.

Henry Bernard1, Jean-Luc Desseyn1, Nana Bartke2, Lennart Kleinjans3, Bernd Stahl2, Clara Belzer3, Jan Knol4, Frédéric Gottrand1, Marie-Odile Husson1.   

Abstract

BACKGROUND: A predominantly T-helper type 2 (Th2) immune response is critical in the prognosis of pulmonary Pseudomonas aeruginosa infection. But the mucosal and systemic immune responses can be influenced by the intestinal microbiota.
METHODS: We assessed the effect of microbiota compositional changes induced by a diet enriched in 5% acidic oligosaccharides derived from pectin (pAOS) on the immune response and outcome of chronic pulmonary P. aeruginosa infection in mice.
RESULTS: pAOS promoted Th1 polarization by increasing interferon γ release, upregulating t-bet gene expression, decreasing interleukin 4 secretion, and downregulating gata3 gene expression. pAOS also sustained the release of keratinocyte chemoattractant, recruited polynuclear leukocytes and macrophages, stimulated M1 macrophage activation and interleukin 10 release, and decreased tumor necrosis factor α release in the lung. These effects led to increased bacterial clearance after the first and second P. aeruginosa infections. pAOS modified the intestinal microbiota by stimulating the growth of species involved in immunity development, such as Bifidobacterium species, Sutturella wadsworthia, and Clostridium cluster XIVa organisms, and at the same time increased the production of butyrate and propionate.
CONCLUSION: These results suggest that pAOS may have beneficial effects by limiting the number and severity of pulmonary exacerbations in patients chronically infected with P. aeruginosa, such as individuals with cystic fibrosis.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  P. aeruginosa lung infection; Th1 and M1 polarization; intestinal microbiota; prebiotics

Mesh:

Substances:

Year:  2014        PMID: 25139019     DOI: 10.1093/infdis/jiu391

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Microbes, metabolites, and the gut-lung axis.

Authors:  Anh Thu Dang; Benjamin J Marsland
Journal:  Mucosal Immunol       Date:  2019-04-11       Impact factor: 7.313

Review 3.  Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease.

Authors:  An Zhou; Yuanyuan Lei; Li Tang; Shiping Hu; Min Yang; Lingyi Wu; Shiming Yang; Bo Tang
Journal:  J Bacteriol       Date:  2021-01-25       Impact factor: 3.490

4.  Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro.

Authors:  Yang Cai; Myrthe S Gilbert; Walter J J Gerrits; Gert Folkerts; Saskia Braber
Journal:  J Adv Res       Date:  2021-11-01       Impact factor: 12.822

Review 5.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

6.  Similar Occurrence of Febrile Episodes Reported in Non-Atopic Children at Three to Five Years of Age after Prebiotics Supplemented Infant Formula.

Authors:  Margriet van Stuijvenberg; José Stam; Christoph Grüber; Fabio Mosca; Sertac Arslanoglu; Gaetano Chirico; Christian P Braegger; Josef Riedler; Günther Boehm; Pieter J J Sauer
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  Streptomycin treatment alters the intestinal microbiome, pulmonary T cell profile and airway hyperresponsiveness in a cystic fibrosis mouse model.

Authors:  Mark Bazett; Marie-Eve Bergeron; Christina K Haston
Journal:  Sci Rep       Date:  2016-01-12       Impact factor: 4.379

8.  The gut microbiota as a modulator of innate immunity during melioidosis.

Authors:  Jacqueline M Lankelma; Emma Birnie; Tassili A F Weehuizen; Brendon P Scicluna; Clara Belzer; Riekelt H Houtkooper; Joris J T H Roelofs; Alex F de Vos; Tom van der Poll; Andries E Budding; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2017-04-19

9.  Pectin-Derived Acidic Oligosaccharides Improve the Outcome of Pseudomonas aeruginosa Lung Infection in C57BL/6 Mice.

Authors:  Henry Bernard; Jean-Luc Desseyn; Frédéric Gottrand; Bernd Stahl; Nana Bartke; Marie-Odile Husson
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

Review 10.  Oligosaccharides: a boon from nature's desk.

Authors:  Seema A Belorkar; A K Gupta
Journal:  AMB Express       Date:  2016-10-03       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.